News
Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal ...
Microbot Medical Inc.’s MBOT share price has surged by 17.44%, which has investors questioning if this is right time to sell.
Please note: If days to cover is between 0 and 1, it is rounded up to 1 on Nasdaq.com. Source: Nasdaq Data Link; Subscribe for short interest feed for all Nasdaq listed securities.
Shares of NASDAQ MBOT opened at $1.70 on Monday. Microbot Medical has a 1 year low of $0.82 and a 1 year high of $3.38. The company has a market capitalization of $59.06 million, a PE ratio of -2. ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Stay updated on market trends for MBOT. Microbot Medical shares are trading higher by 33% during Monday's session. The company is raising $7 million through stock sales and investment options.
Hosted on MSN2mon
Microbot Medical stock target raised to $9 by H.C. WainwrightH.C. Wainwright's valuation of Microbot Medical (NASDAQ:MBOT) stands at an estimated market value of $255 million, or $9 per share, which underpins the revised price target. The current market ...
Currently, MBOT is trading at $1.53 down by 1.92 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results